InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Anthony Doyle, Chief Financial Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 3 open-market SEC Form 4 transactions: 2 purchases worth $642K and 1 sale worth $62K, reported from Nov 23, 21 to May 14, 24. Over this period they have been a net buyer.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 14, 24 | BCRXBIOCRYST PHARMACEUTICALS INC | BUY | 36.3K | $5.57 | $202K |
| Dec 15, 22 | BCRXBIOCRYST PHARMACEUTICALS INC | SELL | 5.7K | $10.90 | $62K |
| Nov 23, 21 | BCRXBIOCRYST PHARMACEUTICALS INC | BUY | 35.3K | $12.48 | $440K |